Bitte beachten Sie, dass die von Ihnen aufgerufene Seite nicht in Ihrer Standardsprache vorliegt. Sie nutzen unsere Plattform nun in einer anderen Sprache.
This statistic shows the epidemiology of chronic hepatitis B in eight countries representing the major pharmaceutical markets worldwide in 2014. In these countries combined, the population number aged 18 years and older with chronic hepatitis B was 34.5 million.
Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Sales for chronic hepatitis B therapeutics 2014 and 2024 by major market
- Basic Statistic Epidemiology of bipolar disorder in 8 major pharma markets 2014
- Premium Statistic Global hip and knee reconstruction market value 2015 vs 2022 by region
- Premium Statistic Forecast of global biosurgery market value 2015 and 2022 by region
- Basic Statistic Bipolar disorder pharma market share in 8 major markets for 2014 & 2024
- Basic Statistic U.S. consumer price index: physician and dental services 1960-2022
- Basic Statistic U.S. specialists and familiarity with biosimilars 2021
- Premium Statistic Number of nurses in Taiwan 2012-2022
- Premium Statistic Number of registered diagnostic radiology specialists in Singapore 2011-2022
- Premium Statistic Percentage of adults with at least one emergency room visit U.S. 2017, by MSA status
About the region
10
- Premium Statistic Pharmaceutical bipolar disorder drug sales 2014 by major market
- Premium Statistic Chronic hepatitis B therapeutic sales share among 8 major markets
- Premium Statistic Global body contouring market share 2015 & 2022 by country
- Premium Statistic Forecast of global point of care diagnostics market value 2015 and 2021 by region
- Basic Statistic Value of select contract pharma manufacturing companies 2022
- Premium Statistic Global point of care diagnostic market revenue 2015 and 2021 by country
- Premium Statistic Enterprise value of top contract pharma research organizations 2022
- Basic Statistic Estimated global per capita health spending 2019 & 2050
- Basic Statistic Main sources of revenue for global mHealth app publishers 2018
- Premium Statistic FDA on breakthrough therapy requests by therapy area 2019
Other regions
10
- Premium Statistic Distribution of new hepatitis C patients in the U.S. by age group 2018
- Basic Statistic Value of the South Korean blood pressure monitor market 2008-2022
- Premium Statistic Value of North American mobility aids and transportation device market 2007-2021
- Basic Statistic Value of North American operating room equipment market 2007-2021, by country
- Premium Statistic Death rate for liver diseases & cirrhosis in Taiwan 2007-2018
- Premium Statistic Share of fatalities in Kuwait by major cause 2019
- Premium Statistic Value of North American patient monitoring accessories market by country 2008-2022
- Premium Statistic Share of fatalities in Saudi Arabia 2019, by major cause
- Premium Statistic Share of fatalities in Qatar by major cause 2019
- Premium Statistic Expenditures on healthcare in the UAE 2011-2027
Related statistics
10
- Premium Statistic Value of North American sterilization equipment market 2007-2021, by country
- Premium Statistic Number of physicians employed in special healthcare in Norway 2012-2021
- Premium Statistic Physician spending as percent total health in each Canadian province 2023
- Basic Statistic Physician spending per capita in Canada by province 2023
- Basic Statistic Provincial/territorial government hospital expenditures in Canada by age 2021
- Premium Statistic Total Canadian other professional's health spending by type and source 2023
- Premium Statistic Hospital spending as share of total health spending in each Canadian province 2023
- Premium Statistic Hospital spending per capita in Canada by province 2023
- Basic Statistic Value of top home care or hospice providers in the U.S. 2021
- Basic Statistic Percentage of adults with an unmet medical need due to cost U.S. 2017, by MSA status
Further related statistics
9
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Cost savings through urgent care vs emergency department 2012
- Net earnings of UnitedHealth Group 2007-2023
- Medicaid long-term care services expenditures by type of service 1990-21
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
- Deaths by prostate cancer in the U.S. 1950-2019
- New cases of mumps in the U.S. 1970-2019
- New cases of shigellosis in the U.S. 1950-2019
- Rate of new cases of tuberculosis in the U.S. 1960-2019
Further Content: You might find this interesting as well
Statistics
- Employer firm revenue of residential care and nursing facilities by tax category 2021
- Cost savings through urgent care vs emergency department 2012
- Net earnings of UnitedHealth Group 2007-2023
- Medicaid long-term care services expenditures by type of service 1990-21
- Deaths by motor vehicle-related injuries in the U.S. 1930-2022
- Deaths by prostate cancer in the U.S. 1950-2019
- New cases of mumps in the U.S. 1970-2019
- New cases of shigellosis in the U.S. 1950-2019
- Rate of new cases of tuberculosis in the U.S. 1960-2019
GlobalData. (January 1, 2016). Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014* [Graph]. In Statista. Retrieved May 23, 2024, from https://www.statista.com/statistics/648514/epidemiology-of-chronic-hepatitis-b-in-major-pharma-markets/
GlobalData. "Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014*." Chart. January 1, 2016. Statista. Accessed May 23, 2024. https://www.statista.com/statistics/648514/epidemiology-of-chronic-hepatitis-b-in-major-pharma-markets/
GlobalData. (2016). Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014*. Statista. Statista Inc.. Accessed: May 23, 2024. https://www.statista.com/statistics/648514/epidemiology-of-chronic-hepatitis-b-in-major-pharma-markets/
GlobalData. "Combined Epidemiology of Chronic Hepatitis B in 8 Major Pharmaceutical Markets in 2014*." Statista, Statista Inc., 1 Jan 2016, https://www.statista.com/statistics/648514/epidemiology-of-chronic-hepatitis-b-in-major-pharma-markets/
GlobalData, Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014* Statista, https://www.statista.com/statistics/648514/epidemiology-of-chronic-hepatitis-b-in-major-pharma-markets/ (last visited May 23, 2024)
Combined epidemiology of chronic hepatitis B in 8 major pharmaceutical markets in 2014* [Graph], GlobalData, January 1, 2016. [Online]. Available: https://www.statista.com/statistics/648514/epidemiology-of-chronic-hepatitis-b-in-major-pharma-markets/